ConductScience.org, home

Paper322649

Timolol, dose response and duration of action.

Zimmerman TJ and 1 other. Arch Ophthalmol, 1977. Cited by 242 papers, by iCite.

Cite this record

ConductScience Library. Timolol, dose response and duration of action. Papers, record 322649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/322649

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Timolol, dose response and duration of action.
PubMed
Journal
Arch Ophthalmol
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
242
iCite
Relative citation ratio, by iCite
14.1
iCite
Revised in PubMed
2019-07-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zimmerman TJT J
2Kaufman HEH E

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlaucomaMajor topic
PropanolaminesMajor topic
TimololMajor topic
Adult
Clinical Trials as Topic
Dose-Response Relationship, Drug
Humans
Intraocular Pressure
Ophthalmic Solutions
Placebos
Time Factors

Source PubMed

Download CSV of topics

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 242 citations.

PMIDTitleJournalYearIn PapersSource
41471311
Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the "Triad" of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy.
Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471311PubMed
38399328Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches.Pharmaceutics2024https://conductscience.org/library/papers/38399328PubMed
37513963Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37513963PubMed
35130584Lab-on-a-Contact Lens: Recent Advances and Future Opportunities in Diagnostics and Therapeutics.Adv Mater2022https://conductscience.org/library/papers/35130584PubMed
32513257Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.Trials2020https://conductscience.org/library/papers/32513257PubMed
30794789Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes.Am J Ophthalmol2019https://conductscience.org/library/papers/30794789PubMed
28480761Topical treatment of glaucoma: established and emerging pharmacology.Expert Opin Pharmacother2017https://conductscience.org/library/papers/28480761PubMed
28399267Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.Invest Ophthalmol Vis Sci2017https://conductscience.org/library/papers/28399267PubMed
27471373The intraocular pressure-lowering properties of intravenous paracetamol.Clin Ophthalmol2016https://conductscience.org/library/papers/27471373PubMed
27041984Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.Clin Ophthalmol2016https://conductscience.org/library/papers/27041984PubMed
25349811Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysis.Int J Ophthalmol2014https://conductscience.org/library/papers/25349811PubMed
21892247Effect of hydrophobic and hydrophilic additives on sol-gel transition and release behavior of timolol maleate from polycaprolactone-based hydrogel.Colloid Polym Sci2011https://conductscience.org/library/papers/21892247PubMed
20040958Recent advances in pharmacotherapy of glaucoma.Indian J Pharmacol2008https://conductscience.org/library/papers/20040958PubMed
19668385Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%).Clin Ophthalmol2008https://conductscience.org/library/papers/19668385PubMed
17041807Topical drug therapy in glaucoma.Wien Med Wochenschr2006https://conductscience.org/library/papers/17041807PubMed
16532287Evolving paradigms in the medical treatment of glaucoma.Int Ophthalmol2004https://conductscience.org/library/papers/16532287PubMed
12034694Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy.Br J Ophthalmol2002https://conductscience.org/library/papers/12034694PubMed
10776828Pharmacological therapy for glaucoma: a review.Drugs2000https://conductscience.org/library/papers/10776828PubMed
10600045Efficacy and adverse effects of medications used in the treatment of glaucoma.Drugs Aging1999https://conductscience.org/library/papers/10600045PubMed
9112163Ocular hypotensive effect of sublingual administration of timolol.Int Ophthalmol1996https://conductscience.org/library/papers/9112163PubMed

See all 47 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/322649

GET https://conductscience.org/api/papers/v1/322649/cited_by?page=2